| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/11/2023 | Immix Biopharma, Inc. | | Grant | Stock Options | 20k | $1.86 | $37.2k | | 08/11/2023 |
| 08/01/2023 | Arcturus Therapeutics Holdings Inc. | ARCT | Grant | Deferred Stock Units | 3.1k | $0.00 | $0 | | 08/01/2023 |
| 08/01/2023 | Arcturus Therapeutics Holdings Inc. | ARCT | Grant | Stock option (right to buy) | 11.9k | $34.92 | $414.5k | | 08/01/2023 |
| 05/19/2023 | Transcode Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 45k | $0.28 | $12.8k | | 05/19/2023 |
| 05/10/2023 | Transcode Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 9.5k | $0.30 | $2.8k | | 05/10/2023 |
| 01/06/2023 | ANAPTYSBIO, INC | ANAB | Grant | Stock Option (right to buy) | 10.6k | $23.23 | $246.2k | | 01/06/2023 |
| 01/06/2023 | ANAPTYSBIO, INC | ANAB | Grant | Restricted Stock Unit | 3.9k | $0.00 | $0 | | 01/06/2023 |
| 12/15/2022 | Arcturus Therapeutics Holdings Inc. | ARCT | Purchase | Common Stock | 2.2k | $18.00 | $40k | Via Alma Life Sciences, LLC | 12/15/2022 |
| 07/14/2022 | Immix Biopharma, Inc. | | Grant | Stock Options | 16k | $2.64 | $42.2k | | 07/14/2022 |
| 06/23/2022 | Arcturus Therapeutics Holdings Inc. | ARCT | Grant | Stock Option (right to buy) | 15k | $16.02 | $240.3k | | 06/23/2022 |
| 06/22/2022 | Transcode Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 9.5k | $1.24 | $11.8k | | 06/22/2022 |
| 02/10/2022 | ANAPTYSBIO, INC | ANAB | Grant | Stock Option (right to buy) | 9.2k | $30.44 | $280k | | 02/10/2022 |
| 06/18/2021 | Arcturus Therapeutics Holdings Inc. | ARCT | Grant | Stock Option (right to buy) | 15k | $35.09 | $526.4k | | 06/18/2021 |
| 02/10/2021 | ANAPTYSBIO, INC | ANAB | Grant | Stock Option (right to buy) | 11k | $29.70 | $326.7k | | 02/10/2021 |
| 01/18/2021 | ANAPTYSBIO, INC | ANAB | Grant | Stock Option (right to buy) | 11k | $26.11 | $287.2k | | 01/18/2021 |
| 01/18/2021 | ANAPTYSBIO, INC | ANAB | Grant | Stock Option (right to buy) | 784 | $26.11 | $20.5k | | 01/18/2021 |
| 10/01/2020 | Pfenex Inc. | PFNX | Other | Stock Option (right to buy) | 18k | $6.43 | $115.7k | | 10/01/2020 |
| 10/01/2020 | Pfenex Inc. | PFNX | Other | Stock Option (right to buy) | 25k | $4.49 | $112.2k | | 10/01/2020 |
| 06/22/2020 | Arcturus Therapeutics Holdings Inc. | ARCT | Grant | Stock Option (right to buy) | 15k | $40.70 | $610.5k | | 06/22/2020 |
| 05/08/2020 | Pfenex Inc. | PFNX | Grant | Stock Option (right to buy) | 18k | $6.43 | $115.7k | | 05/08/2020 |
| 10/25/2019 | Arcturus Therapeutics Holdings Inc. | ARCT | Grant | Stock Option (right to buy) | 15k | $10.23 | $153.4k | | 10/25/2019 |
| 09/13/2019 | Arcturus Therapeutics Holdings Inc. | ARCT | Purchase | Common Stock | 2.3k | $10.58 | $24.3k | Via Alma Life Sciences, LLC | 09/13/2019 |
| 02/28/2019 | Pfenex Inc. | PFNX | Grant | Stock Option (right to buy) | 25k | $4.49 | $112.2k | | 02/28/2019 |